Abomika 500mg Injection
Marketer
Abony Healthcare Limited
Salt Composition
Amikacin (500mg)
Overview Abomika 500mg Injection
Injected Abomika 500mg is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections. Prophylactic use is also indicated in hospitalized individuals to deter infections. Abomika 500mg's mechanism involves bacterial growth inhibition. Administration, strictly by a healthcare provider, is via intravenous infusion or intramuscular injection. Consistent, evenly spaced dosing, as directed, is crucial. Complete the prescribed course; premature cessation risks relapse or infection exacerbation. Typical side effects involve injection site reactions and elevated blood urea. Persistent side effects or treatment inefficacy warrant medical attention. High doses may cause vertigo, nephrotoxicity, and hearing impairment. Adhere rigorously to your physician's instructions, including potential monitoring via kidney function, hearing, and urine tests. Pregnancy is a contraindication; inform your doctor of pregnancy, pregnancy intentions, or breastfeeding.
Uses of Abomika 500mg Injection
Infections caused by bacteria
Major Benefits of Abomika 500mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Abomika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Abomika 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Abomika 500mg Injection works:
Abomika 500mg Injection is a bacterial growth inhibitor, a type of antibiotic. Its mechanism of action involves disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of Abomika 500mg Injection and alcohol presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Abomika 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use only when the potential benefits demonstrably outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Abomika, 500mg, presents no known breastfeeding contraindications. Research in humans indicates minimal to negligible drug transfer via breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Administration of Abomika 500mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Administering Abomika 500mg Injection requires careful consideration for individuals with impaired renal function. Dosage modification of Abomika 500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Abomika 500mg Injection in patients with liver disease is likely safe. Current evidence indicates dose modification may not be necessary, however, physician consultation is advised.
What if you forget to take Abomika 500mg Injection :
Omit a dose of Abomika 500mg Injection? Seek medical advice immediately.
Facts to Know About Abomika 500mg Injection
| Label | Value |
|---|---|
| Type of Compound | Aminoglycoside antibiotics |
| Addictive | None. |
| Medication Classification | Agents against infection |
| Mechanism of Action | Aminoglycoside antibiotics |
3,018 People bought this recently